CD12 poor age stratification...I can't imagine we
Post# of 148187
(Total Views: 458)
Posted On: 10/05/2021 4:34:46 PM
Re: HouseofCards #106723
CD12 poor age stratification...
yes the age stratification fell on amarexs desk and that is inexcusable and nader has every right to be fuming mad, it was a major reason for the trial missing endpoints...DSMC was no help either, FDA no help with dosing issues, and it looks like everyone outside was stacked up against cytodyn.
amarex drops the ball on age strat, on top of "faulty data", and withholding time sensitive critical data, maybe i wouldnt pay them either.
what would trump do? we know the answer to that one
Quote:
I can't imagine we would bring a suit unless we've either already paid them whatever is owed or if we are disputing what is owed based on poor performance (re: poor age stratification in CD12, etc.).
Read More: https://investorshangout.com/post/newpost/605...z78SBMc9Ss
yes the age stratification fell on amarexs desk and that is inexcusable and nader has every right to be fuming mad, it was a major reason for the trial missing endpoints...DSMC was no help either, FDA no help with dosing issues, and it looks like everyone outside was stacked up against cytodyn.
amarex drops the ball on age strat, on top of "faulty data", and withholding time sensitive critical data, maybe i wouldnt pay them either.
what would trump do? we know the answer to that one
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼